331 related articles for article (PubMed ID: 18985628)
1. Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects.
Boyle J; Wolford D; Gargano C; McCrea J; Cummings C; Cerchio K; Lines C
Hum Psychopharmacol; 2009 Jan; 24(1):61-71. PubMed ID: 18985628
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
Blin O; Micallef J; Audebert C; Legangneux E
J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
[TBL] [Abstract][Full Text] [Related]
3. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
Leufkens TR; Lund JS; Vermeeren A
J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
[TBL] [Abstract][Full Text] [Related]
4. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
Farber RH; Burke PJ
Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
[TBL] [Abstract][Full Text] [Related]
5. Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects.
Mathias S; Zihl J; Steiger A; Lancel M
Neuropsychopharmacology; 2005 Apr; 30(4):833-41. PubMed ID: 15602499
[TBL] [Abstract][Full Text] [Related]
6. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.
Walsh JK; Mayleben D; Guico-Pabia C; Vandormael K; Martinez R; Deacon S
Sleep Med; 2008 May; 9(4):393-402. PubMed ID: 17765013
[TBL] [Abstract][Full Text] [Related]
8. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
[TBL] [Abstract][Full Text] [Related]
9. Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects.
Boyle J; Danjou P; Alexander R; Calder N; Gargano C; Agrawal N; Fu I; McCrea JB; Murphy MG
Br J Clin Pharmacol; 2009 Feb; 67(2):180-90. PubMed ID: 19094161
[TBL] [Abstract][Full Text] [Related]
10. A comparative study on the effects of brotizolam and flurazepam on sleep and performance in the elderly.
Mamelak M; Csima A; Buck L; Price V
J Clin Psychopharmacol; 1989 Aug; 9(4):260-7. PubMed ID: 2671059
[TBL] [Abstract][Full Text] [Related]
11. A double-blind study to establish the residual effects of zopiclone on performance in healthy volunteers.
Lader M; Denney SC
Int Pharmacopsychiatry; 1982; 17 Suppl 2():98-108. PubMed ID: 7188379
[TBL] [Abstract][Full Text] [Related]
12. Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor.
Rosenzweig P; Patat A; Zieleniuk I; Cimarosti I; Allain H; Gandon JM
Clin Pharmacol Ther; 1998 Aug; 64(2):211-22. PubMed ID: 9728902
[TBL] [Abstract][Full Text] [Related]
13. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
Boyle J; Trick L; Johnsen S; Roach J; Rubens R
Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
[TBL] [Abstract][Full Text] [Related]
14. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo.
Leufkens TR; Vermeeren A
J Clin Psychopharmacol; 2009 Oct; 29(5):432-8. PubMed ID: 19745642
[TBL] [Abstract][Full Text] [Related]
15. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
Hajak G; Hedner J; Eglin M; Loft H; Stórustovu SI; Lütolf S; Lundahl J;
Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients.
Ponciano E; Freitas F; Camara J; Faria M; Barreto M; Hindmarch I
Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():69-77. PubMed ID: 2201731
[TBL] [Abstract][Full Text] [Related]
17. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
Erman M; Seiden D; Zammit G; Sainati S; Zhang J
Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers.
Hindmarch I; Legangneux E; Stanley N; Emegbo S; Dawson J
Br J Clin Pharmacol; 2006 Nov; 62(5):538-45. PubMed ID: 17061961
[TBL] [Abstract][Full Text] [Related]
19. Objective measurements of daytime sleepiness and performance comparing quazepam with flurazepam in two adult populations using the Multiple Sleep Latency Test.
Dement WC
J Clin Psychiatry; 1991 Sep; 52 Suppl():31-7. PubMed ID: 1680123
[TBL] [Abstract][Full Text] [Related]
20. Residual effects of zolpidem, triazolam, rilmazafone and placebo in healthy elderly subjects: a randomized double-blind study.
Uemura SI; Kanbayashi T; Wakasa M; Satake M; Ito W; Shimizu K; Shioya T; Shimizu T; Nishino S
Sleep Med; 2015 Nov; 16(11):1395-1402. PubMed ID: 26498242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
